asa guidelines for glp 1 agonists Anesthetic Considerations Patients Taking Glucagon-Like Peptide-1 The New Weight Management Meds

Safety Considerations and Who Should Avoid Tirzepatide The most common side effects reported in trials were gastrointestinalnausea, vomiting, diarrhea, and constipationtypically mild to moderate and improving over time

Another problem is that patients do not always follow their treatment regimens

Implications for Patient Care and Provider Guidance The study serves as a wake-up call for healthcare providers to engage in ongoing conversations with patients about medication benefits, potential side effects, and adherence

Significant levels of liraglutide were found in the brain of mice 30 minutes and 3 hours after intraperitoneal injection, indicating that liraglutide could cross the BBB (125)

These milestones highlight the growing regulatory and clinical momentum supporting expanded uses Ongoing trials are also exploring the impact of GLP-1 agonists on cardiovascular outcomes, liver health, and even neurodegenerative diseases, reinforcing their value in treating systemic metabolic disorders